Clinical Trial: A Study of Inotuzumab and Blinatumomab in People With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia

U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313852) titled 'A Study of Inotuzumab and Blinatumomab in People With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia' on Dec. 30, 2025.

Brief Summary: The purpose of this study is to find out whether combining inotuzumab and blinatumomab is a safe and effective treatment for participants with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL).

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: B-cell Acute Lymphoblastic Leukemia B-Cell Acute Lymphoblastic Leukemia, Adult B-ALL

Intervention: DRUG: Blinatumomab Injection

Blinatumomab given via subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor:...